Clinic
Family Health Centers of San Diego, INC.
Family Health Centers of San Diego, INC. was paid $97.05M by Medicaid between Jan 2018 and Dec 2024, across 269 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 87% of everything it billed.
33Billing provider infoFAMILY HEALTH CENTERS OF SAN DIEGO, INC.
EL CAJON, CA 92020
EL CAJON, CA 92020
33aNPI1932561198assigned 03/25/2016
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$97.05M
24GClaims1,070,895
24DCodes billed269
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in California
Rank by total paid#27 of 826
Median peer was paid$4.05M
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ROMAN, RICARDO controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,847 | $8.34M | |
| 2019 | 88,068 | $9.27M | |
| 2020 | 146,806 | $9.32M | |
| 2021 | 187,219 | $15.21M | |
| 2022 | 163,815 | $14.39M | |
| 2023 | 226,929 | $19.95M | |
| 2024incomplete | 201,211 | $20.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 87% | 415,111 | 302,028 | $84.21M |
| 00003 | Internal/system code - not a standard HCPCS code | 12% | 42,332 | 30,686 | $11.90M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 63,755 | 59,641 | $114K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 12,200 | 12,175 | $87K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 93,686 | 84,724 | $76K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 5,898 | 3,348 | $69K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 2,161 | 1,864 | $54K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 8,185 | 5,915 | $53K |
| V2020 | Frames, purchases | <1% | 11,701 | 11,684 | $47K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 7,054 | 6,289 | $44K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 6,170 | 6,150 | $40K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 7,980 | 7,969 | $31K |
257 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 21,446 | $25K |
| 0004A | <1% | 365 | $24K | |
| 92015 | Determination of refractive state | <1% | 17,733 | $23K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,798 | $20K |
| 0001A | <1% | 301 | $19K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 1,262 | $19K |
| 0002A | <1% | 283 | $18K | |
| 0124A | <1% | 232 | $14K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,574 | $13K |
| 93000 | <1% | 5,904 | $12K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 2,124 | $12K |
| 0013A | <1% | 175 | $12K | |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 170 | $10K |
| 98940 | <1% | 2,154 | $9K | |
| 92341 | <1% | 1,866 | $8K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 126 | $8K |
| 0071A | <1% | 94 | $6K | |
| 0072A | <1% | 85 | $6K | |
| 97161 | <1% | 108 | $4K | |
| 92250 | <1% | 6,508 | $4K | |
| 0154A | <1% | 125 | $4K | |
| G9920 | Screening performed and negative | <1% | 1,215 | $3K |
| 96156 | <1% | 167 | $3K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,003 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,292 | $3K |
| G0469 | Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 50 | $3K |
| J3490 | Unclassified drugs | <1% | 158 | $3K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,794 | $3K |
| 99401 | <1% | 717 | $3K | |
| 90480 | <1% | 713 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,935 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,928 | $2K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 210 | $2K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,283 | $2K |
| 0173A | <1% | 73 | $2K | |
| 81025 | <1% | 8,354 | $2K | |
| 97803 | <1% | 4,114 | $2K | |
| 0012A | <1% | 28 | $2K | |
| 0081A | <1% | 54 | $2K | |
| 98960 | <1% | 1,201 | $1K | |
| 90651 | <1% | 2,256 | $981.08 | |
| 0134A | <1% | 14 | $938.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,314 | $799.24 |
| 58300 | <1% | 16 | $489.04 | |
| 11721 | <1% | 326 | $487.54 | |
| 99402 | <1% | 118 | $413.27 | |
| 80061 | Lipid panel | <1% | 6,380 | $336.13 |
| 80053 | Comprehensive metabolic panel | <1% | 6,755 | $328.81 |
| 86592 | <1% | 2,946 | $292.90 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,706 | $247.92 |
| 90686 | <1% | 6,186 | $220.46 | |
| 81002 | <1% | 9,406 | $213.68 | |
| 86480 | <1% | 2,047 | $209.24 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,574 | $129.47 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,999 | $119.24 |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 151 | $117.74 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,185 | $100.38 |
| 86803 | <1% | 2,271 | $97.08 | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 83 | $44.91 |
| 81003 | <1% | 2,860 | $43.82 | |
| 87210 | <1% | 2,291 | $37.03 | |
| 58301 | <1% | 13 | $37.02 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,578 | $34.69 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 133 | $21.80 |
| 86704 | <1% | 1,189 | $21.66 | |
| 81015 | <1% | 3,111 | $20.38 | |
| 86706 | <1% | 1,576 | $19.02 | |
| 87340 | <1% | 705 | $18.24 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,557 | $15.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,059 | $14.03 |
| 99000 | <1% | 8,716 | $10.89 | |
| 82043 | <1% | 704 | $5.08 | |
| 96127 | <1% | 3,692 | $4.81 | |
| 82570 | <1% | 946 | $4.69 | |
| 99173 | <1% | 4,627 | $2.34 | |
| X3904 | 0% | 15,432 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 2,508 | $0.00 |
| 90710 | 0% | 791 | $0.00 | |
| 2028F | 0% | 1,680 | $0.00 | |
| 90670 | 0% | 2,768 | $0.00 | |
| 84439 | 0% | 264 | $0.00 | |
| 90648 | 0% | 530 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 1,898 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 2,998 | $0.00 |
| 90461 | 0% | 3,624 | $0.00 | |
| 83540 | 0% | 711 | $0.00 | |
| 90707 | 0% | 722 | $0.00 | |
| 99404 | 0% | 479 | $0.00 | |
| 90756 | 0% | 2,011 | $0.00 | |
| 90713 | 0% | 490 | $0.00 | |
| 84450 | 0% | 625 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 11,872 | $0.00 |
| 90750 | 0% | 230 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 5,985 | $0.00 |
| 91322 | 0% | 139 | $0.00 | |
| 80354 | 0% | 228 | $0.00 | |
| Z6200 | 0% | 633 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 5,386 | $0.00 |
| 91312 | 0% | 70 | $0.00 | |
| X4110 | 0% | 224 | $0.00 | |
| 85610 | 0% | 130 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 3,677 | $0.00 |
| Z6400 | 0% | 3,603 | $0.00 | |
| 90715 | 0% | 2,092 | $0.00 | |
| 82947 | 0% | 872 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 2,418 | $0.00 |
| 96160 | 0% | 2,910 | $0.00 | |
| 92134 | 0% | 959 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 2,951 | $0.00 |
| 2022F | 0% | 198 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 1,167 | $0.00 |
| 90700 | 0% | 1,083 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 2,663 | $0.00 |
| 90633 | 0% | 2,727 | $0.00 | |
| 59425 | 0% | 70 | $0.00 | |
| 82565 | 0% | 29 | $0.00 | |
| 90785 | 0% | 441 | $0.00 | |
| Z6308 | 0% | 39 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 176 | $0.00 |
| 90734 | 0% | 487 | $0.00 | |
| 20611 | 0% | 26 | $0.00 | |
| Z6304 | 0% | 1,024 | $0.00 | |
| 90837 | Psychotherapy session, about an hour | 0% | 507 | $0.00 |
| 91321 | 0% | 517 | $0.00 | |
| 82248 | 0% | 65 | $0.00 | |
| 69209 | 0% | 299 | $0.00 | |
| 91308 | 0% | 47 | $0.00 | |
| 90681 | 0% | 499 | $0.00 | |
| 99201 | 0% | 200 | $0.00 | |
| Z6300 | 0% | 530 | $0.00 | |
| 84460 | 0% | 608 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 458 | $0.00 |
| 99442 | 0% | 210 | $0.00 | |
| Z6500 | 0% | 70 | $0.00 | |
| Z6414 | 0% | 51 | $0.00 | |
| 84156 | 0% | 69 | $0.00 | |
| 90687 | 0% | 54 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 134 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 17 | $0.00 |
| 82247 | 0% | 65 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 296 | $0.00 |
| 80076 | 0% | 12 | $0.00 | |
| Z6208 | 0% | 30 | $0.00 | |
| 92553 | 0% | 448 | $0.00 | |
| 90658 | 0% | 41 | $0.00 | |
| 97164 | 0% | 168 | $0.00 | |
| 90380 | 0% | 61 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 322 | $0.00 |
| L1812 | Knee orthosis, elastic with joints, prefabricated, off-the-shelf | 0% | 56 | $0.00 |
| 82274 | 0% | 32 | $0.00 | |
| 90685 | 0% | 23 | $0.00 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 0% | 41 | $0.00 |
| L1820 | Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 0% | 45 | $0.00 |
| 90661 | 0% | 349 | $0.00 | |
| 90653 | 0% | 29 | $0.00 | |
| 90714 | 0% | 41 | $0.00 | |
| 90746 | 0% | 30 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 29 | $0.00 |
| 84550 | 0% | 101 | $0.00 | |
| 99188 | 0% | 58 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 270 | $0.00 |
| 10060 | 0% | 12 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 30 | $0.00 |
| 90473 | 0% | 36 | $0.00 | |
| 3078F | 0% | 112 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 18 | $0.00 |
| 85007 | 0% | 25 | $0.00 | |
| Z1034 | 0% | 11,593 | $0.00 | |
| 90680 | 0% | 1,883 | $0.00 | |
| 86140 | 0% | 304 | $0.00 | |
| Z6406 | 0% | 887 | $0.00 | |
| Z6410 | 0% | 985 | $0.00 | |
| 85651 | 0% | 794 | $0.00 | |
| 83550 | 0% | 639 | $0.00 | |
| 90674 | 0% | 539 | $0.00 | |
| 99381 | 0% | 1,021 | $0.00 | |
| Z1038 | 0% | 712 | $0.00 | |
| 36416 | 0% | 146 | $0.00 | |
| 90619 | 0% | 622 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 14,400 | $0.00 |
| X3924 | 0% | 6,732 | $0.00 | |
| 90696 | 0% | 553 | $0.00 | |
| 82951 | 0% | 1,365 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 485 | $0.00 |
| 90698 | 0% | 1,516 | $0.00 | |
| Z6204 | 0% | 1,320 | $0.00 | |
| 87081 | 0% | 725 | $0.00 | |
| 85018 | 0% | 4,564 | $0.00 | |
| 90716 | 0% | 971 | $0.00 | |
| 82728 | 0% | 603 | $0.00 | |
| Z6402 | 0% | 763 | $0.00 | |
| 97802 | 0% | 1,165 | $0.00 | |
| 87070 | 0% | 1,474 | $0.00 | |
| L1810 | Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 0% | 16 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 2,757 | $0.00 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 72 | $0.00 |
| 90677 | 0% | 1,119 | $0.00 | |
| 81001 | 0% | 309 | $0.00 | |
| 91315 | 0% | 65 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 1,491 | $0.00 |
| 94760 | 0% | 1,114 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 199 | $0.00 |
| 99070 | 0% | 182 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,167 | $0.00 |
| Z1032 | 0% | 1,186 | $0.00 | |
| 91317 | 0% | 61 | $0.00 | |
| 99406 | 0% | 808 | $0.00 | |
| X3908 | 0% | 2,018 | $0.00 | |
| 92551 | 0% | 7,616 | $0.00 | |
| 90744 | 0% | 1,464 | $0.00 | |
| 3074F | 0% | 113 | $0.00 | |
| 20610 | 0% | 1,971 | $0.00 | |
| 90381 | 0% | 58 | $0.00 | |
| 2023F | 0% | 1,141 | $0.00 | |
| X3906 | 0% | 167 | $0.00 | |
| 90688 | 0% | 179 | $0.00 | |
| X4304 | 0% | 137 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 54 | $0.00 |
| 92002 | 0% | 106 | $0.00 | |
| 97162 | 0% | 277 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 14 | $0.00 |
| 99459 | 0% | 325 | $0.00 | |
| 90739 | 0% | 106 | $0.00 | |
| 99441 | 0% | 227 | $0.00 | |
| X3910 | 0% | 138 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 124 | $0.00 |
| 80050 | General health panel | 0% | 60 | $0.00 |
| 99385 | 0% | 39 | $0.00 | |
| 90697 | 0% | 1,427 | $0.00 | |
| 87428 | 0% | 3,082 | $0.00 | |
| 99443 | 0% | 12 | $0.00 | |
| 3008F | 0% | 114 | $0.00 | |
| 90732 | 0% | 82 | $0.00 | |
| 90656 | 0% | 672 | $0.00 | |
| 3072F | 0% | 113 | $0.00 | |
| 11055 | 0% | 13 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 60 | $0.00 |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 0% | 49 | $0.00 |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 0% | 111 | $0.00 |
| 4000F | 0% | 57 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 183 | $0.00 |
| 91301 | 0% | 19 | $0.00 | |
| X3902 | 0% | 79 | $0.00 | |
| 90694 | 0% | 143 | $0.00 | |
| 0011A | 0% | 19 | $0.00 | |
| 99383 | 0% | 12 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 69 | $0.00 |
| 83690 | 0% | 67 | $0.00 | |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | 0% | 29 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 16 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 28 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 38 | $0.00 |
| A9300 | Exercise equipment | 0% | 12 | $0.00 |
| 90723 | 0% | 21 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 15 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 0% | 27 | $0.00 |
| 96161 | 0% | 85 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROMAN, RICARDO (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.